Interleukin-22 (IL-22) is a novel cytokine of the IL-10 family, which has shown evidence in recent studies to alleviate metabolic syndrome in obese mice, improve insulin resistance, and regulate the expression of genes related to lipogenesis (Hasnain et al., 2014; Wang et al., 2014). Here, IL22 is linked to Insulin resistance.